The Global Business for Ukraine is pleased to share that our member CheckEye has been included in the list of the TOP-10 Ukrainian startups to watch, according to Tech EU.
CheckEye is a Ukraine-based startup that develops an AI-powered cloud-based solution for the early detection of diabetic retinopathy and other prevalent eye conditions. As of today, CheckEye has a developed MVP and is in the process of conducting clinical trials in partnership with the Ukrainian Diabetes Federation and The Filatov Institute of Eye Diseases and Tissue Therapy in Odesa.
The initial field results have demonstrated a 92% accuracy in diabetic retinopathy (DR) diagnosis and in 82% CheckEye determines the correct stage, the results which dramatically outperform those by human doctors.
When implemented and integrated in a public healthcare system, CheckEye’s solution can compensate the lack of specialist consultants or adequate infrastructure/facilities in rural areas where access to secondary healthcare services is limited.
Despite the war, the CheckEye’s team continues to work. In November 2022, CheckEye rolled out its pilot eye screening project for the IDPs in Western Ukraine. As a member of GB4U, CheckEye is actively involved in networking events in Ukraine and abroad presenting its solution to experts, partners, investors internationally.
CheckEye is currently in its seed stage and is actively pitching for investment. To support CheckEye, please take a look at our Investment Map of Ukraine.
We are proud of having such resilient, proactive, and future-driven companies like CheckEye on board.